Setting-Referrals to a paediatric oncology clinic and a dermatology clinic at two city hospitals.
Patients-The group receiving chemotherapy comprised all 32 patients with acute lymphatic leukaemia, lymphoma, and rhabdomyosarcoma who were attending the paediatric oncology clinic on two mornings a week during October 1987 to March 1988. The group who had completed treatment comprised 32 patients who were attending for follow up during the same period and who matched the first group for age and sex. Thirty two other patients attending the dermatology outpatient clinic with unrelated skin conditions served as controls.
Endpoint-Definite increase in numbers of moles on children after a course of chemotherapy.
Measurements and main results-Moles were counted by one observer on defined areas ofthe body and divided into those <3 mm and ¢n3 mm diameter.
Patients receiving chemotherapy had a similar number of moles to the control group. By contrast patients who had completed chemotherapy had significant increases both in moles <3 mm and :3 mm and in the total number of moles. 
Results
Patients who had completed chemotherapy had the Noduring treatment 25 most moles. They occurred particularly on the trunk Noaftersuccessful (figure), but they also occurred on arms and legs and on _ement 26 both palms and soles. Some of the moles were macular, some were papular, and pigmentation and outline were TABLE iII-Mean number variable. None was examined histologically. Table I (95% confidence intervalsi gives the details of patients in the three groups and table II shows the diagnoses in the chemotherapy Size ofmoles treatmengt treatment groups. The patients with acute lymphatic leukaemia were given chemotherapy according to the <31mm 4383(168 to6 5 regimens of the United Kingdom acute lymphoblastic leukaemia trial, which entail two or three years of All 42-0(19-2to64 chemotherapy and cranial irradiation. Those with lymphoma were treated with multiple chemotherap<OOlComparedwitho peutic agents and radiotherapy, and those treated for rhabdomyosarcoma received chemotherapy with treatment compared multiple drugs. Those who had completed treatment and controls. had finished a mean of 28 months (range 3-70) before. Table IV gives t] Table III shows the mean numbers of moles accord-moles on acral sites; ing to size in the three groups. Analysis of variance palms and soles of tl showed a highly siginificant difference among the three of patients both dui groups (p<0001). This was true when comparing total treatment (13/32) h numbers of moles and also when counting moles <3 controls (3/32). Whe mm and ¢3 mm. By using the Newman-Keuls test and on these sites with ti a significance level of 5% a significant difference was those who had comr found between the numbers of moles on patients after higher numbers of m groups (p<0 05). There was no significant difference among the three groups in acute exposure to ultraviolet light or skin types.
Discussion
Barker and MacDonald reported a case of eruptive dysplastic naevus syndrome in a 20 year old man given immunosuppressive treatment after renal transplantation.3 This is the only previously reported case of increase in melanocytic lesions (excluding melanoma) after chemotherapy. Surveys of the prevalence of moles in normal populations have shown that the number of moles increases during childhood, reaches a peak in early adulthood, and then declines throughout life.-7 The number of moles varies according to race. A few studies have looked at moles in non-white subjects,8 but none has assessed moles according to age and none has included Asian populations. MacKie et al have reported on the only study of white people in Britain that included children and adults.' They studied naevi :3 mm diameter and found that the mean number of moles was 3 in children under 10 and 20 in people aged [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] . Naevi were slightly more prevalent in male subjects. All but 10 ofthe 96 children in our study were white, and the numbers of moles both in the control group and in the group still receiving chemotherapy were comparable with the findings ofMacKie et al.
Little is known about the biology of benign naevi. Race and heredity seem to be important, and in the dysplastic naevus syndrome inheritance has been described. 9 We matched patients for race as far as possible, as this may affect the numbers of naevi.
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Asians have fewer moles than white people. Hormonal factors play a part, as evidenced by the increase in moles at puberty and by reports of both darkening of moles and their increase during pregnancy.' Moles may contain oestrogen and progesterone receptors, which would account for these changes. The effects of exposure to ultraviolet light are not clear, studies having given conflicting results. '2 13 There are reports of sudden increases in numbers of moles occurring spontaneously,'4 during puberty" and pregnancy,'" and after treatment with corticotrophin and cortisone. 6 Most of our patients were prepubertal, and the fact that they were matched for age and sex should have eliminated any bias. All but five of our patients were treated with prednisolone. This may have contributed to our findings, but whether these were due to immunosuppression or another mechanism is unknown.
We not only counted moles of n3 mm diameter as in the study by MacKie et aF but in addition we counted smaller moles, as we consider that children have a number of smaller, darkly pigmented lesions which are junctional naevi. We did not sample any of the lesions for biopsy, as none looked dysplastic and the patients were too young. There was no difference among the three groups in acute exposure to ultraviolet light or skin types. It would have been an advantage to assess our patients before chemotherapy, but this was not possible. Nevertheless, the increase in numbers of moles after treatment supports our belief that the observation may be important.
Our patients showed a significant increase in numbers of moles after immunosuppression compared with controls. A The increase in malignant melanoma is thought to be due to less efficient immune surveillance as a result of immunosuppressive effects on the immune system. 9-2' Little is known about the long term effects of intensive courses of chemotherapy on the immune system. The lack of excess tumours in the long term-that is, 10 years after chemotherapy -may suggest a return of the immune system to normal. This would be in keeping with the observations ofour patients-namely, that the moles seem to arise towards the end of or immediately after completion of chemotherapy. Long term studies are required to see whether the numbers of naevi continue to increase over the years subsequent to chemotherapy. Both our patients who had completed chemotherapy and those still having chemotherapy had increased numbers of acral moles, suggesting that this is the first site exposed to the immunosuppressive effect on the melanocytes. On analysing the numbers of acral moles, however, the significant difference lay between those who had completed treatment and the other two groups.
Having increased numbers of benign melanocytic naevi seems to be one of the strongest risk factors for the development of malignant melanoma,222' and so these children may be a group prone to that disease. Acral moles may also have an increased malignant potential,24 and so it is possibly also a matter for concern that out patients had an excess number of naevi on the palms and soles. This view, however, is disputed by some doctors."'
The numbers of children successfully treated for childhood malignancy are increasing, which emphasises the importance of prospective studies of these naevi. We are at present undertaking a prospective study of patients who have yet to complete their chemotherapy. It is likely that subsequent research based on our observations will add to our understanding of the biological mechanisms responsible for the development of benign melanocytic naevi. In the mean time these patients should be warned of the detrimental effects ofultraviolet light and advised to avoid excessive exposure to the sun and to apply adequate sun protection. Doctors Subjects completed a detailed questionnaire on exercise habits, history of sports related injuries, and medical history. In 1988 the subjects also had a rheumatological examination of the legs and an x ray examination of the hips (supine anteroposterior view of pelvis). All radiographs were scored "blind" by an experienced radiologist not associated with the study. Each radiograph was scored for joint space narrowing, subchondral sclerosis, and osteophyte formation. On the films the joint space, expressed as the distance between the ossified surfaces and representing the thickness of the joint cartilage, was measured cranially. Joint space narrowing was classified as grade zero if cartilage thickness was -3 mm, grade 1 if <3 mm, grade 2 if <2 5 mm, and grade 3 if <2 mm. Subchondral sclerosis and osteophyte formation were scored zero (absent) to 3 (excessive) according to standard criteria.9 A simple radiological index of degenerative hip disease was then computed by summing the classifications of joint space narrowing, sclerosis, and
